RSV is a seasonal virus that lands tens of thousands of young children in the hospital every year.On Thursday, advisors to the FDA voted in favor of approving a long-acting antibody that protects infants from RSV. Christoph Soeder/Picture Alliance via Getty Images A panel of advisers to the Food and Drug Administration have recommended that the agency approve a new antibody drug to protect infants from serious lung illnesses caused by respiratory syncytial virus, also known as RSV.
#development #authorities #getty-images #recommendations #kansas-city #astrazeneca #young-children #side-effects #clinical-trials #high-levels
[
add
]
[
|
|
...
]